2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide

C109H99F4N13O12S8 — CID 159542819

IUPAC2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide
SMILESCc1ccccc1CC(=O)Nc1nc(-c2ccc3c(c2)CCN3S(=O)(=O)c2ccccc2C)c(C)s1.Cc1ccccc1S(=O)(=O)N1CCc2cc(-c3nc(NC(=O)Cc4cccc(F)c4)sc3C)ccc21.Cc1ccccc1S(=O)(=O)N1CCc2cc(-c3nc(NC(=O)Cc4ccccc4C(F)(F)F)sc3C)ccc21.Cc1ccccc1S(=O)(=O)N1CCc2cc(-c3nc(NC(=O)Cc4ccccn4)sc3C)ccc21
InChIInChI=1S/C28H24F3N3O3S2.C28H27N3O3S2.C27H24FN3O3S2.C26H24N4O3S2/c1-17-7-3-6-10-24(17)39(36,37)34-14-13-20-15-21(11-12-23(20)34)26-18(2)38-27(33-26)32-25(35)16-19-8-4-5-9-22(19)28(29,30)31;1-18-8-4-6-10-21(18)17-26(32)29-28-30-27(20(3)35-28)23-12-13-24-22(16-23)14-15-31(24)36(33,34)25-11-7-5-9-19(25)2;1-17-6-3-4-9-24(17)36(33,34)31-13-12-20-16-21(10-11-23(20)31)26-18(2)35-27(30-26)29-25(32)15-19-7-5-8-22(28)14-19;1-17-7-3-4-9-23(17)35(32,33)30-14-12-19-15-20(10-11-22(19)30)25-18(2)34-26(29-25)28-24(31)16-21-8-5-6-13-27-21/h3-12,15H,13-14,16H2,1-2H3,(H,32,33,35);4-13,16H,14-15,17H2,1-3H3,(H,29,30,32);3-11,14,16H,12-13,15H2,1-2H3,(H,29,30,32);3-11,13,15H,12,14,16H2,1-2H3,(H,28,29,31)
InChIKeyMEKUOVHIGGZUEZ-UHFFFAOYSA-N
MW2115.60 g/mol
LogP22.30
Rot. Bonds24

About 2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide

2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide (PubChem CID 159542819) has the molecular formula C109H99F4N13O12S8 and a molecular weight of 2115.60 g/mol. Its IUPAC name is 2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide.

Molecular Properties

Compound Name2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide
PubChem CID159542819
Molecular FormulaC109H99F4N13O12S8
Molecular Weight2115.60 g/mol
Exact Mass2113.52
IUPAC Name2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide
SMILESCc1ccccc1CC(=O)Nc1nc(-c2ccc3c(c2)CCN3S(=O)(=O)c2ccccc2C)c(C)s1.Cc1ccccc1S(=O)(=O)N1CCc2cc(-c3nc(NC(=O)Cc4cccc(F)c4)sc3C)ccc21.Cc1ccccc1S(=O)(=O)N1CCc2cc(-c3nc(NC(=O)Cc4ccccc4C(F)(F)F)sc3C)ccc21.Cc1ccccc1S(=O)(=O)N1CCc2cc(-c3nc(NC(=O)Cc4ccccn4)sc3C)ccc21
InChIInChI=1S/C28H24F3N3O3S2.C28H27N3O3S2.C27H24FN3O3S2.C26H24N4O3S2/c1-17-7-3-6-10-24(17)39(36,37)34-14-13-20-15-21(11-12-23(20)34)26-18(2)38-27(33-26)32-25(35)16-19-8-4-5-9-22(19)28(29,30)31;1-18-8-4-6-10-21(18)17-26(32)29-28-30-27(20(3)35-28)23-12-13-24-22(16-23)14-15-31(24)36(33,34)25-11-7-5-9-19(25)2;1-17-6-3-4-9-24(17)36(33,34)31-13-12-20-16-21(10-11-23(20)31)26-18(2)35-27(30-26)29-25(32)15-19-7-5-8-22(28)14-19;1-17-7-3-4-9-23(17)35(32,33)30-14-12-19-15-20(10-11-22(19)30)25-18(2)34-26(29-25)28-24(31)16-21-8-5-6-13-27-21/h3-12,15H,13-14,16H2,1-2H3,(H,32,33,35);4-13,16H,14-15,17H2,1-3H3,(H,29,30,32);3-11,14,16H,12-13,15H2,1-2H3,(H,29,30,32);3-11,13,15H,12,14,16H2,1-2H3,(H,28,29,31)
InChIKeyMEKUOVHIGGZUEZ-UHFFFAOYSA-N
XLogP22.30
TPSA330.37 Ų
H-Bond Donors4
H-Bond Acceptors21
Rotatable Bonds24
Heavy Atoms146
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002115.60
LogP ≤ 522.30
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1021

Analyze 2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide?
The IUPAC name of 2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide (CID 159542819) is 2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide.
What is the SMILES notation for 2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide?
The canonical SMILES for 2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide is Cc1ccccc1CC(=O)Nc1nc(-c2ccc3c(c2)CCN3S(=O)(=O)c2ccccc2C)c(C)s1.Cc1ccccc1S(=O)(=O)N1CCc2cc(-c3nc(NC(=O)Cc4cccc(F)c4)sc3C)ccc21.Cc1ccccc1S(=O)(=O)N1CCc2cc(-c3nc(NC(=O)Cc4ccccc4C(F)(F)F)sc3C)ccc21.Cc1ccccc1S(=O)(=O)N1CCc2cc(-c3nc(NC(=O)Cc4ccccn4)sc3C)ccc21.
What is the InChIKey of 2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide?
The InChIKey is MEKUOVHIGGZUEZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H24F3N3O3S2.C28H27N3O3S2.C27H24FN3O3S2.C26H24N4O3S2/c1-17-7-3-6-10-24(17)39(36,37)34-14-13-20-15-21(11-12-23(20)34)26-18(2)38-27(33-26)32-25(35)16-19-8-4-5-9-22(19)28(29,30)31;1-18-8-4-6-10-21(18)17-26(32)29-28-30-27(20(3)35-28)23-12-13-24-22(16-23)14-15-31(24)36(33,34)25-11-7-5-9-19(25)2;1-17-6-3-4-9-24(17)36(33,34)31-13-12-20-16-21(10-11-23(20)31)26-18(2)35-27(30-26)29-25(32)15-19-7-5-8-22(28)14-19;1-17-7-3-4-9-23(17)35(32,33)30-14-12-19-15-20(10-11-22(19)30)25-18(2)34-26(29-25)28-24(31)16-21-8-5-6-13-27-21/h3-12,15H,13-14,16H2,1-2H3,(H,32,33,35);4-13,16H,14-15,17H2,1-3H3,(H,29,30,32);3-11,14,16H,12-13,15H2,1-2H3,(H,29,30,32);3-11,13,15H,12,14,16H2,1-2H3,(H,28,29,31).
What are the key properties of 2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide?
2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide has a molecular weight of 2115.60 g/mol, XLogP of 22.30, 24 rotatable bonds, 4 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(3-fluorophenyl)-N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-(2-methylphenyl)acetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-pyridin-2-ylacetamide;N-[5-methyl-4-[1-(2-methylphenyl)sulfonyl-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]-2-[2-(trifluoromethyl)phenyl]acetamide is sourced from PubChem (CID 159542819), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).